Colon cancer survival varies by insurance type

April 20, 2018

(HealthDay)—Compared to patients with private insurance, colon cancer survival is lower for patients with no insurance or with Medicaid, according to a study published in the May issue of Diseases of the Colon & Rectum.

Dianne Pulte, M.D., from the German Cancer Research Center in Heidelberg, and colleagues examined survival for with colon cancer by insurance type (Medicaid, uninsured, or other insurance) using a sample derived from the Surveillance, Epidemiology, and End Results 18 database.

The researchers found that of the 55,432 patients, 13.7 percent had Medicaid, 7.5 percent no insurance, and 78.8 percent other insurance. Compared to patients with other insurance, those with Medicaid or without insurance were more likely to have metastatic disease. Survival was lowest for patients with Medicaid, with three-year survival estimates of 57.0 percent for Medicaid, 61.2 percent for uninsured, and 75.6 percent for other insurance. Even after adjustment for stage, especially for later-stage disease, significant disparities persisted, but the discrepancy decreased when only patients with stage I to II disease who had definitive surgery and resection of ≥12 lymph nodes were included in the analysis.

"Colon cancer survival is lower for patients with no insurance or with Medicaid than for those with ," the authors write. "Differences in rates of definitive surgery and adequate explain some of this disparity."

Explore further: Does health insurance status affect childhood cancer survival?

More information: Abstract/Full Text

Related Stories

Does health insurance status affect childhood cancer survival?

September 11, 2017
A new study examines whether insurance status may affect survival in children diagnosed with cancer. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings suggest largely similar ...

Study links health insurance status and head and neck cancer diagnoses, outcomes

February 18, 2016
Compared to patients with non-Medicaid insurance, uninsured patients and patients with Medicaid are more likely to present with advanced stages of head and neck cancer and have higher overall and cancer-specific mortality ...

Affordable Care Act lowered uninsured rate for cancer survivors

February 15, 2018
The percentage of cancer survivors without health insurance decreased substantially after implementation of the Affordable Care Act (ACA), reports a study in the March issue of Medical Care.

ACA Medicaid expansion cut disparities in cancer care for minorities, poor

September 26, 2017
States that fully expanded their Medicaid programs under the Affordable Care Act cut their rates of uninsured cancer patients by more than half between 2011 and 2014. Black patients and those living in the highest poverty ...

Differences in cancer survival by type of insurance

December 4, 2017
(HealthDay)—From 1997 to 2014, improvements in cancer survival were mainly limited to patients with private or Medicare insurance, according to a study published online Nov. 30 in JAMA Oncology.

Studies link cancer patient's survival time to insurance status

September 23, 2016
Privately insured people with two types of cancer were diagnosed earlier and lived longer than those who were uninsured or were covered by Medicaid, according to two new studies.

Recommended for you

Surgery unnecessary for many prostate cancer patients

December 13, 2018
Otherwise healthy men with advanced prostate cancer may benefit greatly from surgery, but many with this diagnosis have no need for it. These conclusions were reached by researchers after following a large group of Scandinavian ...

Combining three treatment strategies may significantly improve melanoma treatment

December 12, 2018
A study by a team led by a Massachusetts General Hospital (MGH) investigator finds evidence that combining three advanced treatment strategies for malignant melanoma—molecular targeted therapy, immune checkpoint blockade ...

An integrated approach to finding new treatments for breast cancer

December 12, 2018
Unraveling the complexity of cancer biology can lead to the identification new molecules involved in breast cancer and prompt new avenues for drug development. And proteogenomics, an integrated, multipronged approach, seems ...

New insight into stem cell behaviour highlights therapeutic target for cancer treatment

December 12, 2018
Research led by the University of Plymouth and Technische Universität Dresden has identified a new therapeutic target for cancer treatment and tissue regeneration – a protein called Prominin-1.

Lethal combination: Drug cocktail turns off the juice to cancer cells

December 12, 2018
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth—this was discovered by researchers from the University of Basel's Biozentrum two years ago. In a follow-up study, ...

Researchers use computer model to predict prostate cancer progression

December 12, 2018
An international team of cancer researchers from Denmark and Germany have used cancer patient data to develop a computer model that can predict the progression of prostate cancer. The model is currently being implemented ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.